Kalos Management, Inc. Elanco Animal Health Inc Transaction History

Kalos Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Jun 21, 2022	SELL	$24.65 - $29.0 $937,809 - $1.1 Million	-38,045 Closed	0 $0
Q4 2021 Feb 03, 2022	BUY	$27.74 - $34.09 $69,017 - $84,815	2,488 Added 7.0%	38,045 $1.26 Million
Q3 2021 Nov 10, 2021	SELL	$29.2 - $36.72 $110,522 - $138,985	-3,785 Reduced 9.62%	35,557 $1.18 Million
Q2 2021 Aug 11, 2021	BUY	$28.76 - $35.98 $30,514 - $38,174	1,061 Added 2.77%	39,342 $1.17 Million
Q1 2021 May 13, 2021	BUY	$27.85 - $34.49 $180,857 - $223,978	6,494 Added 20.43%	38,281 $1.24 Million
Q4 2020 Feb 11, 2021	BUY	$27.53 - $33.79 $875,096 - $1.07 Million	31,787 New	31,787 $924,000

438

473M

4.62M

753K

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $6.63B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

Get notified when there are updates to the investment portfolio of Kalos Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Kalos Management, Inc. with notifications on news.